4.6 Article

Clusterin transcript variants expression in thyroid tumor: a potential marker of malignancy?

Journal

BMC CANCER
Volume 15, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/s12885-015-1348-0

Keywords

CLU; Gene expression; Thyroid tumour

Categories

Funding

  1. MIUR [FIRB-MERIT RBNE08YFN3_005, PON01_01297 R&C 2007-2013-VIRTUALAB]

Ask authors/readers for more resources

Background: Clusterin (CLU) is a ubiquitous multifunctional factor involved in neoplastic transformation. The CLU transcript variants and protein forms play a crucial role in balancing cells proliferation and death. Methods: We investigated the regulation of CLU transcript variants expression in an in vivo model system consisting of both neoplastic tissues and fine needle aspiration biopsy (FNAB) samples isolated from patients undergoing thyroidectomy. Results: The immunohistochemical analyses showed an overall CLU up-regulation in papillary carcinoma. A specific CLU2 transcript variant increase was registered using qPCR in papillary carcinomas while CLU1 decreased. In addition, the analysis of CLU transcripts expression level showed an increase of the CLU2 transcript in the TIR 3 patients with histologically confirmed thyroid cancer. Conclusions: Our results suggest the existence of a specific alteration of CLU2: CLU1 ratio towards CLU2, thus providing the first circumstantial evidence for the potential use of CLU transcript variants as effective biomarkers for a more accurate assessment of the so called indeterminate thyroid nodules.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Endocrinology & Metabolism

Findings for iGlarLixi versus BIAsp 30 confirmed in groups of people with type 2 diabetes with different biomedical characteristics

Philip D. Home, Rory J. McCrimmon, Julio Rosenstock, Matthias Bluher, Katrin Pegelow, Lydie Melas-Melt, Khier Djaballah, Francesco Giorgino

Summary: The aim of this study was to investigate the impact of baseline participant characteristics on the outcomes of the SoliMix study. The findings showed that the treatment effects of iGlarLixi were consistent across various baseline characteristics, supporting its use as an effective and well-tolerated treatment option for people with type 2 diabetes.

DIABETES OBESITY & METABOLISM (2023)

Review Endocrinology & Metabolism

Professional continuous glucose monitoring in patients with diabetes mellitus: A systematic review and meta-analysis

Sergio Di Molfetta, Irene Caruso, Angelo Cignarelli, Annalisa Natalicchio, Sebastio Perrini, Luigi Laviola, Francesco Giorgino

Summary: This study aimed to evaluate the effect of professional continuous glucose monitoring (p-CGM)-based care on glucose control in type 1 and type 2 diabetes patients. The use of p-CGM was found to significantly reduce glycated haemoglobin (HbA1c) levels without increasing hypoglycaemia compared to standard care.

DIABETES OBESITY & METABOLISM (2023)

Article Dentistry, Oral Surgery & Medicine

Medication-related osteonecrosis of the jaw triggered by endodontic failure in oncologic patients

Angela Tempesta, Saverio Capodiferro, Simona Di Nanna, Silvia D'Agostino, Marco Dolci, Antonio Scarano, Gianluca Gambarini, Eugenio Maiorano, Gianfranco Favia, Luisa Limongelli

Summary: This study describes the association between endodontic treatment failure and MRONJ in oncologic patients. The results showed that teeth with failed endodontic treatment may be a risk factor for the development of MRONJ before receiving antiresorptive and antiangiogenic drug therapies. Therefore, careful evaluation of these patients is necessary prior to the initiation of drug treatment.

ORAL DISEASES (2023)

Editorial Material Endocrinology & Metabolism

Metformin use in pregnancy: efficacy, safety, and potential benefits

G. P. Sorice, M. Caporusso, A. Cignarelli, S. Perrini, A. Natalicchio, F. Giorgino

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2023)

Review Biochemistry & Molecular Biology

Type 2 Diabetes and Alzheimer's Disease: The Emerging Role of Cellular Lipotoxicity

Nicola Marrano, Giuseppina Biondi, Anna Borrelli, Martina Rella, Tommaso Zambetta, Ludovico Di Gioia, Mariangela Caporusso, Giancarlo Logroscino, Sebastio Perrini, Francesco Giorgino, Annalisa Natalicchio

Summary: Type 2 diabetes and Alzheimer's disease are major health issues with a close relationship. Lipotoxicity may be the missing link connecting the pathogenesis of these two diseases. Obesity, the main cause of lipotoxicity, is a major risk factor for both conditions. This review provides a comprehensive overview of the common molecular pathways activated by lipotoxicity in type 2 diabetes and Alzheimer's disease, suggesting potential new therapeutic perspectives.

BIOMOLECULES (2023)

Review Endocrinology & Metabolism

New insights into the treatment of obesity

Matthias Blueher, Mohini Aras, Louis J. Aronne, Rachel L. Batterham, Francesco Giorgino, Linong Ji, Kirsi H. Pietilainen, Oliver Schnell, Elena Tonchevska, John P. H. Wilding

Summary: Obesity is a chronic disease with increasing prevalence worldwide and is associated with various health risks. The treatment of obesity includes behavioral interventions, pharmacotherapy, and bariatric surgery, but long-term weight maintenance is challenging. Recent advances in understanding the pathophysiology of obesity have led to the development of novel and effective therapies, such as semaglutide and tirzepatide, which have shown promising weight loss effects and improvement in cardiometabolic risk factors. These new agents may bridge the gap between traditional treatments and achieve better outcomes in obesity management.

DIABETES OBESITY & METABOLISM (2023)

Article Dentistry, Oral Surgery & Medicine

Oral lesions with immunohistochemical evidence of Sars-CoV-2 in swab-negative post-COVID syndrome

Luisa Limongelli, Gianfranco Favia, Eugenio Maiorano, Antonio D'Amati, Alberto Pispero, Giuseppe Ingravallo, Giuseppe Barile, Angela Tempesta, Fabio Dell'Olio, Rosaria Arianna Siciliani, Saverio Capodiferro

Summary: There is growing evidence of post-COVID condition/syndrome, which occurs in recovered patients and involves various organs/systems, as well as persisting taste dysfunction. The symptoms persist for more than 12 weeks and are related to the persistence of the virus, although the pathogenesis varies by organs or systems.

ORAL DISEASES (2023)

Review Genetics & Heredity

Immunohistochemical Expression of Programmed Cell Death Ligand 1 (PD-L1) in Human Cutaneous Malignant Melanoma: A Narrative Review with Historical Perspectives

Gerardo Cazzato, Teresa Lettini, Anna Colagrande, Irma Trilli, Francesca Ambrogio, Carmelo Laface, Paola Parente, Eugenio Maiorano, Giuseppe Ingravallo

Summary: Programmed death-ligand 1 (PD-L1) is an important ligand for programmed death-1 (PD-1) receptor and is found in myeloid, lymphoid, normal epithelial cells, and cancer. The interaction between PD-1 and PD-L1 is crucial for immunological tolerance development and cancer progression. In the case of malignant melanoma, the immunohistochemical expression of PD-L1 is used to guide therapeutic choices. However, there are various methods used for immunohistochemistry and inconsistent results in the literature. This review aims to discuss the achievements, challenges, and potential solutions in this field.

GENES (2023)

Review Medicine, General & Internal

Metastatic Lung Cancer to the Head and Neck: A Clinico-Pathological Study on 21 Cases with Narrative Review of the Literature

Saverio Capodiferro, Antonio d'Amati, Giuseppe Barile, Fabio Dell'Olio, Luisa Limongelli, Angela Tempesta, Rosaria Arianna Siciliani, Giuseppe Ingravallo, Mauro Mastropasqua, Giuseppe Colella, Ciro Emiliano Boschetti, Chiara Copelli, Eugenio Maiorano, Gianfranco Favia

Summary: Metastases to the oral cavity and head and neck from lung cancer are rare and typically occur in advanced stages of the disease. In even rarer cases, they may be the first indication of metastatic disease. This study retrospectively examined 21 cases of lung cancer metastases to the head and neck and proposed an immunohistochemical panel for identifying the primary tumor. Data from previous studies were also reviewed.

JOURNAL OF CLINICAL MEDICINE (2023)

Review Oncology

T Cell Immunoglobulin and Mucin Domain 3 (TIM-3) in Cutaneous Melanoma: A Narrative Review

Gerardo Cazzato, Eliano Cascardi, Anna Colagrande, Teresa Lettini, Alessandra Filosa, Francesca Arezzo, Carmelo Lupo, Nadia Casatta, Vera Loizzi, Cristina Pellegrini, Maria Concetta Fargnoli, Eugenio Maiorano, Gerolamo Cicco, Roberto Tamma, Giuseppe Ingravallo

Summary: T cell immunoglobulin and mucin domain 3 (TIM-3) is an inhibitory immunocheckpoint that has been investigated for its role in the tumour microenvironment of melanoma. This review provides the most up-to-date knowledge about TIM-3 in melanoma and discusses future prospects and potential applications.

CANCERS (2023)

Review Health Care Sciences & Services

GONE WITH THE WIND: The Transitory Effects of COVID-19 on the Gynecological System

Miriam Dellino, Antonella Vimercati, Antonio D'Amato, Gianluca Raffaello Damiani, Antonio Simone Lagana, Ettore Cicinelli, Vincenzo Pinto, Antonio Malvasi, Salvatore Scacco, Andrea Ballini, Leonardo Resta, Giuseppe Ingravallo, Eugenio Maiorano, Gerardo Cazzato, Eliano Cascardi

Summary: The advent of coronavirus vaccines has alleviated the most serious symptoms of COVID-19, making it no longer an insurmountable global problem. However, there are still many extrapulmonary symptoms, including gynecological alterations, that raise questions about the causal link between COVID-19, vaccines, and gynecological health. The clinical impact of post-COVID-19 gynecological alterations on the female population is mainly determined by their duration, and the extent of these symptoms is still poorly understood.

JOURNAL OF PERSONALIZED MEDICINE (2023)

Article Endocrinology & Metabolism

The real-world observational prospective study of health outcomes with dulaglutide and liraglutide in patients with type 2 diabetes (TROPHIES): Final, 24-month analysis of time to first significant treatment change, treatment persistence and clinical outcomes

Francesco Giorgino, Bruno Guerci, Martin Fuechtenbusch, Jeremie Lebrec, Kristina Boye, Marco Orsini Federici, Elke Heitmann, Anne Dib, Maria Yu, Helene Sapin, Luis-Emilio Garcia-Perez

Summary: The TROPHIES study presented the final results, indicating that patients initiating dulaglutide had a longer duration without significant treatment changes and higher treatment persistence compared to those initiating liraglutide. Both drugs showed similar and clinically meaningful reductions in glycated haemoglobin (HbA1c) and weight.

DIABETES OBESITY & METABOLISM (2023)

Article Endocrinology & Metabolism

The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Final patient-reported outcomes at 24 months

Kristina S. Boye, Jeremie Lebrec, Anne Dib, Elke Heitmann, Marco Orsini Federici, Maria Yu, Helene Sapin, Annabel Barrett, Bruno Guerci, Francesco Giorgino, Martin Fuechtenbusch, Luis-Emilio Garcia-Perez

Summary: This study reports the health-related patient-reported outcomes (PROs) of patients with T2D initiating their first injectable glucose-lowering medication (GLM) with two common GLP-1RAs. The results show that dulaglutide had more significant improvements in PRO scores compared to liraglutide, and patients were more satisfied with the injection device of dulaglutide.

DIABETES OBESITY & METABOLISM (2023)

Review Oncology

Polybrominated Diphenyl Ethers (PBDEs) and Human Health: Effects on Metabolism, Diabetes and Cancer

Valerio Renzelli, Marco Gallo, Lelio Morviducci, Giampiero Marino, Alberto Ragni, Enzo Tuveri, Antongiulio Faggiano, Rossella Mazzilli, Annalisa Natalicchio, Maria Chiara Zatelli, Monica Montagnani, Stefano Fogli, Dario Giuffrida, Antonella Argentiero, Romano Danesi, Stella D'Oronzo, Stefania Gori, Tindara Franchina, Antonio Russo, Matteo Monami, Laura Sciacca, Saverio Cinieri, Annamaria Colao, Angelo Avogaro, Graziano Di Cianni, Francesco Giorgino, Nicola Silvestris

Summary: Endocrine disruptors, such as PBDEs, can interfere with the endocrine system and potentially affect glucose metabolism, endocrine diseases, and cancer risk. However, the evidence regarding their impact is often conflicting. A deeper understanding of the relationship between exposure to endocrine disruptors and obesity, diabetes, metabolic disturbances, and cancer can guide public health interventions.

CANCERS (2023)

Article Oncology

Artificial Intelligence Applied to a First Screening of Naevoid Melanoma: A New Use of Fast Random Forest Algorithm in Dermatopathology

Gerardo Cazzato, Alessandro Massaro, Anna Colagrande, Irma Trilli, Giuseppe Ingravallo, Nadia Casatta, Carmelo Lupo, Andrea Ronchi, Renato Franco, Eugenio Maiorano, Angelo Vacca

Summary: Malignant melanoma, especially the nevoid variant, is difficult to diagnose correctly, even for experienced pathologists. Artificial intelligence has revolutionized the biomedical field and can potentially improve the diagnosis and treatment of nevoid melanoma. This study applies a fast random forest algorithm to naevoid melanomas to develop a clinical protocol aimed at reducing misdiagnosis. The results demonstrate the potential integration of this algorithm into the business process modeling and notation approach.

CURRENT ONCOLOGY (2023)

No Data Available